Testing Vivatlac for Irritable Bowel Syndrome
Part of Digestive system clinical trials.
This study tests a product called Vivatlac to see if it can help people with Irritable Bowel Syndrome (IBS). If you have moderate-to-severe IBS and haven't taken probiotics or antibiotics recently, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Irritable Bowel Syndrome (IBS) by a doctor
- Your IBS symptoms are moderate to severe (a symptom score of 175 or higher)
- You haven't taken probiotics or antibiotics in the past 3 months
- You don't have other serious health conditions like cancer, uncontrolled high blood pressure, or liver/kidney disease
- You don't have other bowel diseases like Crohn's, colitis, or celiac disease
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 9 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.
This study looks at people with irritable bowel syndrome (IBS) to understand whether it’s connected to lactose intolerance. Participants will be selected based on specific lactose breath and tolerance test results and recent imaging that doesn’t show other causes for symptoms.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This study tests whether a fecal microbiota transplant (FMT) — transferring healthy stool bacteria into your gut — can help people with severe irritable bowel syndrome (IBS) that hasn't improved after trying at least two other treatments.
This study tests whether a specific diet plan can improve symptoms in people with IBS that is not constipation (IBS-D or IBS-M). If you qualify, you’ll complete symptom questionnaires and follow the study diet for the trial period to see if symptoms improve.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.